A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bjh.16390
PubMed Identifier: 32077091
Publication URI: http://europepmc.org/abstract/MED/32077091
Type: Journal Article/Review
Parent Publication: British Journal of Haematology
Issue: 6
ISSN: 0007-1048